966
M. Tori et al. / Tetrahedron: Asymmetry 10 (1999) 961–971
dimethylcyclohexanone (14 g, 37%); 4a; oil: [α]D20.5 −6.2 (c 1.04, CHCl3); CD [θ]300nm −410 (CHCl3);
∆ε=−0.13; FT-IR 1740, 1700 cm−1; 1H NMR (600 MHz, CDCl3): δ 0.93 (3H, d, J=6.8 Hz), 1.02 (3H,
s), 1.60 (1H, m), 1.67 (1H, m), 1.76 (1H, m), 1.80 (1H, m), 1.84 (1H, m), 1.95 (1H, m), 2.01 (1H, ddd,
J=14, 11.2, 5.2 Hz), 2.22 (1H, ddd, J=12.9, 11.2, 5.1 Hz), 2.31 (1H, m), 2.33 (1H, ddd, J=12.9, 11.2, 5.1
Hz), 2.43 (1H, ddd, J=14.3, 10.7, 5.9 Hz), 3.67 (3H, s); 13C NMR (50 MHz, CDCl3): δ 15.3 (CH3), 18.4
(CH3), 24.4 (CH2), 28.9 (CH2), 29.1 (CH2), 30.4 (CH2), 38.1 (CH2), 38.4 (CH), 51.2 (C), 51.4 (CH3),
174.1 (C), 215.0 (C); MS m/z 212 (M+), 197, 181, 168, 153, 139, 126 (base), 111, 96, 83, 69, 55, 41;
HRMS found m/z 212.1436; calcd for C12H20O3 212.1413.
3.3. Preparation of ester 4b from (2RS,3R)-2,3-dimethylcyclohexanone 10b
The imine was similarly prepared from (2RS,3R)-2,3-dimethylcyclohexanone 10b (18.4 g, 0,15 mol),
(S)-(−)-1-phenylethylamine (23 mL, 0.17 mol), and TsOH (2 g) in benzene (200 mL), followed by
Michael addition to methyl acrylate (15.8 mL, 0.17 mol). Workup and purification as described before
22
afforded ester 4b (18.3 g, 59%, >99.5% ee); [α]D −19.1 (c 1.2, CHCl3); CD [θ]297.5nm −970 (CHCl3);
∆ε=−0.29.
3.4. Reaction of imine 3c, prepared from (2RS,3R)-2,3-dimethylcyclohexanone 10b and (R)-(+)-1-
phenylethylamine, with methyl acrylate
The imine 3c was similarly prepared from (2RS,3R)-2,3-dimethylcyclohexanone 10b (1.4 g, 11.1
mmol), (R)-(+)-1-phenylethylamine (1.5 mL, 11.1 mmol), and TsOH (140 mg) in benzene (15 mL),
followed by Michael addition to methyl acrylate (1 mL, 11.1 mmol). Workup and purification as
described before in combination of HPLC afforded ester 4c (7.1 mg, 0.3%), 12 (35 mg, 1.5%), 13 (9.4
mg, 0.4%), 14 (7.1 mg, 0.3%), and 15 (47 mg, 2%).
12; oil: [α]D20 +56.7 (c 1.04, CHCl3); CD [θ]295nm +5300 (CHCl3) ∆ε=+1.6; FT-IR 1740, 1705 cm−1;
1H NMR (600 MHz, C6D6) δ 0.70 (3H, d, J=6.6 Hz), 0.98 (3H, d, J=6.6 Hz), 1.10 (1H, m), 1.18 (1H,
m), 1.26 (1H, m), 1.32 (1H, m), 1.43 (1H, m), 1.50 (1H, m), 1.90 (1H, m), 1.93 (1H, m), 2.10 (1H, m),
2.11 (1H, m), 2.24 (1H, m), 3.37 (3H, s); 13C NMR (100 MHz, CDCl3): δ 13.4 (CH3), 20.4 (CH3), 26.2
(CH2), 28.7 (CH2), 29.9 (CH2), 31.9 (CH2), 40.0 (CH), 48.1 (CH), 49.1 (CH), 51.6 (CH3), 173.5 (C),
215.6 (C); MS m/z 212 (M+), 180 (base), 165, 152, 126, 111, 95, 83, 69, 55; HRMS found m/z 212.1393;
calcd for C12H20O3 212.1422.
13; oil: [α]D21 −43.5 (c 0.54, CHCl3); CD [θ]295nm −3300 (CHCl3); ∆ε=−1.0; FT-IR 1740, 1710 cm−1;
1H NMR (600 MHz, CDCl3): δ 0.92 (3H, d, J=6.9 Hz), 1.02 (3H, d, J=7.4 Hz), 1.37 (1H, ddd, J=13, 11,
4.1 Hz), 1.57 (1H, m), 1.61 (1H, m), 1.67 (1H, dq, J=13, 4.1 Hz), 2.01 (1H, m), 2.03 (1H, m), 2.05 (1H,
m), 2.32 (1H, ddd, J=15.9, 8.2, 6.8 Hz), 2.37 (1H, ddd, J=15.9, 8.5, 6.6 Hz), 2.46 (1H, m), 2.52 (1H,
ddd, J=12, 7.1, 4.9 Hz), 3.66 (3H, s); MS m/z 212 (M+), 180 (base), 165, 152, 138, 126, 111, 95, 83, 69,
55; HRMS found m/z 212.1426; calcd for C12H20O3 212.1412.
14; oil: [α]D21+6.4 (c 0.95, CHCl3); CD [θ]299nm +1100 (CHCl3); ∆ε=+0.32; FT-IR 1740, 1705 cm−1;
1H NMR (600 MHz, CDCl3) δ 1.01 (3H, d, J=6.3 Hz), 1.05 (3H, d, J=6.3 Hz), 1.34 (1H, ddd, J=13, 13,
3.7 Hz), 1.45 (1H, m), 1.50 (1H, m), 1.53 (1H, m), 1.83 (1H, dq, J=13.5, 3.3 Hz), 2.04 (1H, m), 2.06 (1H,
m), 2.08 (1H, m), 2.32 (1H, ddd, J=16, 8, 6.5 Hz), 2.35 (1H, m), 2.41 (1H, ddd, J=16, 8, 6.5 Hz), 3.66
(3H, s); 13C NMR (50 MHz, CDCl3) 11.9 (CH3), 20.8 (CH3), 24.9 (CH2), 31.8 (CH2), 33.7 (CH2),34.6
(CH2), 42.4 (CH), 49.3 (CH), 51.6 (CH3), 52.1 (CH), 173.9 (C), 213.0 (C); MS m/z 212 (M+), 180 (base),
165, 152, 138, 126, 111, 95, 83, 69, 55; HRMS found m/z 212.1412; calcd for C12H20O3 212.1412.